Developmental Deltamethrin Exposure Causes Persistent Changes in Dopaminergic Gene Expression, Neurochemistry, and Locomotor Activity in Zebrafish

Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are more susceptible to the adverse effects of pesticides. We used the zebrafish model to test the hypothesis that developmental exposure to low d...

Full description

Saved in:
Bibliographic Details
Published inToxicological sciences Vol. 146; no. 2; pp. 235 - 243
Main Authors Kung, Tiffany S, Richardson, Jason R, Cooper, Keith R, White, Lori A
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.08.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are more susceptible to the adverse effects of pesticides. We used the zebrafish model to test the hypothesis that developmental exposure to low doses of the pyrethroid deltamethrin results in persistent alterations in dopaminergic gene expression, neurochemistry, and locomotor activity. Zebrafish embryos were treated with deltamethrin (0.25-0.50 μg/l), at concentrations below the LOAEL, during the embryonic period [3-72 h postfertilization (hpf)], after which transferred to fresh water until the larval stage (2-weeks postfertilization). Deltamethrin exposure resulted in decreased transcript levels of the D1 dopamine (DA) receptor (drd1) and increased levels of tyrosine hydroxylase at 72 hpf. The reduction in drd1 transcripts persisted to the larval stage and was associated with decreased D2 dopamine receptor transcripts. Larval fish, exposed developmentally to deltamethrin, had increased levels of homovanillic acid, a DA metabolite. Since the DA system is involved in locomotor activity, we measured the swim activity of larval fish following a transition to darkness. Developmental exposure to deltamethrin significantly increased larval swim activity which was attenuated by concomitant knockdown of the DA transporter. Acute exposure to methylphenidate, a DA transporter inhibitor, increased swim activity in control larva, while reducing swim activity in larva developmentally exposed to deltamethrin. Developmental exposure to deltamethrin causes locomotor deficits in larval zebrafish, which is likely mediated by dopaminergic dysfunction. This highlights the need to understand the persistent effects of low-dose neurotoxicant exposure during development.
AbstractList Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are more susceptible to the adverse effects of pesticides. We used the zebrafish model to test the hypothesis that developmental exposure to low doses of the pyrethroid deltamethrin results in persistent alterations in dopaminergic gene expression, neurochemistry, and locomotor activity. Zebrafish embryos were treated with deltamethrin (0.25–0.50 μg/l), at concentrations below the LOAEL, during the embryonic period [3–72 h postfertilization (hpf)], after which transferred to fresh water until the larval stage (2-weeks postfertilization). Deltamethrin exposure resulted in decreased transcript levels of the D1 dopamine (DA) receptor ( drd1 ) and increased levels of tyrosine hydroxylase at 72 hpf. The reduction in drd1 transcripts persisted to the larval stage and was associated with decreased D2 dopamine receptor transcripts. Larval fish, exposed developmentally to deltamethrin, had increased levels of homovanillic acid, a DA metabolite. Since the DA system is involved in locomotor activity, we measured the swim activity of larval fish following a transition to darkness. Developmental exposure to deltamethrin significantly increased larval swim activity which was attenuated by concomitant knockdown of the DA transporter. Acute exposure to methylphenidate, a DA transporter inhibitor, increased swim activity in control larva, while reducing swim activity in larva developmentally exposed to deltamethrin. Developmental exposure to deltamethrin causes locomotor deficits in larval zebrafish, which is likely mediated by dopaminergic dysfunction. This highlights the need to understand the persistent effects of low-dose neurotoxicant exposure during development.
Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are more susceptible to the adverse effects of pesticides. We used the zebrafish model to test the hypothesis that developmental exposure to low doses of the pyrethroid deltamethrin results in persistent alterations in dopaminergic gene expression, neurochemistry, and locomotor activity. Zebrafish embryos were treated with deltamethrin (0.25-0.50 μg/l), at concentrations below the LOAEL, during the embryonic period [3-72 h postfertilization (hpf)], after which transferred to fresh water until the larval stage (2-weeks postfertilization). Deltamethrin exposure resulted in decreased transcript levels of the D1 dopamine (DA) receptor (drd1) and increased levels of tyrosine hydroxylase at 72 hpf. The reduction in drd1 transcripts persisted to the larval stage and was associated with decreased D2 dopamine receptor transcripts. Larval fish, exposed developmentally to deltamethrin, had increased levels of homovanillic acid, a DA metabolite. Since the DA system is involved in locomotor activity, we measured the swim activity of larval fish following a transition to darkness. Developmental exposure to deltamethrin significantly increased larval swim activity which was attenuated by concomitant knockdown of the DA transporter. Acute exposure to methylphenidate, a DA transporter inhibitor, increased swim activity in control larva, while reducing swim activity in larva developmentally exposed to deltamethrin. Developmental exposure to deltamethrin causes locomotor deficits in larval zebrafish, which is likely mediated by dopaminergic dysfunction. This highlights the need to understand the persistent effects of low-dose neurotoxicant exposure during development.
Author White, Lori A
Richardson, Jason R
Cooper, Keith R
Kung, Tiffany S
Author_xml – sequence: 1
  givenname: Tiffany S
  surname: Kung
  fullname: Kung, Tiffany S
  organization: Joint Graduate Program in Toxicology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA, Department of Biochemistry and Microbiology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA and
– sequence: 2
  givenname: Jason R
  surname: Richardson
  fullname: Richardson, Jason R
  organization: Department of Environmental and Occupational Medicine, Environmental and Occupational Health Sciences Institute, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
– sequence: 3
  givenname: Keith R
  surname: Cooper
  fullname: Cooper, Keith R
  organization: Department of Biochemistry and Microbiology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA and Department of Environmental and Occupational Medicine, Environmental and Occupational Health Sciences Institute, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
– sequence: 4
  givenname: Lori A
  surname: White
  fullname: White, Lori A
  email: lawhite@aesop.rutgers.edu
  organization: Department of Biochemistry and Microbiology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA and lawhite@aesop.rutgers.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25912032$$D View this record in MEDLINE/PubMed
BookMark eNpVkctOwzAQRS0EouWxZIv8AYT6kTjJBgm1vKQKWMCGTeQ4k8aQ2JHtVvQ3-GJSFSpYzWjm3jMa3SO0b6wBhM4ouaQk55NgP73Sk496RbJ0D42HoYhIzvL9n16QjIzQkffvhFAqSH6IRizJKSOcjdHXDFbQ2r4DE2SLZ9AG2UFonDb45rO3fukAT-XSg8fP4Lz2YVDiaSPNYhgNqpntZacNuIVW-A4MbHwOvNfWXOBHWDqrGugGo1tfYGkqPLfKdjZYh69V0Csd1hvOG5RO1to3J-iglq2H0596jF5vb16m99H86e5hej2PFM_SENFY1gAZkUTmleJC1TEkschKyuuYVawkFRNxXCZQSiEZCAEZy1jKKiA1j1N-jK623H5ZdlCp4S8n26J3upNuXVipi_8bo5tiYVdFnNCUJHwARFuActZ7B_XOS0mxCafYhlNswxn0538P7tS_afBvoJuU2A
CitedBy_id crossref_primary_10_1016_j_chemosphere_2023_138251
crossref_primary_10_3390_ijms222312714
crossref_primary_10_1016_j_ecoenv_2024_116359
crossref_primary_10_47470_0869_7922_2023_31_1_47_53
crossref_primary_10_1016_j_chemosphere_2019_125416
crossref_primary_10_1177_07482337231177753
crossref_primary_10_1002_tox_22376
crossref_primary_10_1016_j_ntt_2019_03_001
crossref_primary_10_2478_aiht_2019_70_3263
crossref_primary_10_1016_j_aquatox_2018_03_022
crossref_primary_10_1016_j_scitotenv_2021_149938
crossref_primary_10_1002_etc_3951
crossref_primary_10_1007_s00401_019_02033_9
crossref_primary_10_1007_s10646_024_02763_x
crossref_primary_10_2903_j_efsa_2021_6599
crossref_primary_10_1016_j_ecoenv_2019_01_057
crossref_primary_10_1039_C8RA07871H
crossref_primary_10_1016_j_chemosphere_2018_12_011
crossref_primary_10_1016_j_aquatox_2022_106246
crossref_primary_10_1007_s00128_022_03645_w
crossref_primary_10_1016_j_toxlet_2018_05_020
crossref_primary_10_1111_gbb_12460
crossref_primary_10_1016_j_scitotenv_2022_153623
crossref_primary_10_3390_ijms17122137
crossref_primary_10_3390_life14050640
crossref_primary_10_1007_s11356_020_07902_5
crossref_primary_10_1016_j_ecoenv_2021_112917
crossref_primary_10_1016_j_scitotenv_2019_134299
crossref_primary_10_1021_acs_est_9b00637
crossref_primary_10_1016_j_scitotenv_2019_134870
crossref_primary_10_3389_fnins_2018_00615
crossref_primary_10_3390_jmse8020073
crossref_primary_10_1016_j_scitotenv_2020_141878
crossref_primary_10_3389_fphar_2022_837810
crossref_primary_10_1016_j_ntt_2016_02_004
crossref_primary_10_1021_acs_est_3c10682
crossref_primary_10_1016_j_cbpc_2023_109584
crossref_primary_10_1007_s12403_021_00384_x
crossref_primary_10_1007_s40572_018_0185_0
crossref_primary_10_1016_j_brainresbull_2019_10_002
crossref_primary_10_1016_j_scitotenv_2022_156027
crossref_primary_10_3390_toxics11040353
crossref_primary_10_1080_03601234_2023_2232277
crossref_primary_10_1007_s11596_019_1995_5
crossref_primary_10_1016_j_chemosphere_2019_02_174
crossref_primary_10_3390_molecules28176303
crossref_primary_10_1016_j_brainresbull_2022_01_004
Cites_doi 10.1016/j.neuropharm.2004.07.034
10.1007/s00213-013-3212-8
10.1016/S0161-813X(02)00031-1
10.1096/fj.14-260901
10.1016/j.tox.2006.10.015
10.1093/toxsci/kfr111
10.1016/S0161-813X(01)00063-8
10.1016/j.neuro.2008.12.015
10.1289/ehp.5619
10.1289/ehp.02110507
10.1016/S0959-437X(00)00074-5
10.1016/j.bbr.2012.08.032
10.1016/S0166-4328(97)00175-7
10.1038/sj.jes.7500507
10.1006/pest.1999.2440
10.1016/j.envint.2012.07.007
10.1080/15459620902850907
10.1016/0168-9525(94)90091-4
10.1016/j.taap.2005.06.003
10.1016/0306-4522(92)90388-I
10.1111/j.1471-4159.1990.tb05803.x
10.1016/0305-0491(88)90156-3
10.1016/j.taap.2006.07.011
10.1016/0091-3057(93)90532-X
10.1289/ehp.7254
10.1016/j.biopsych.2005.02.002
10.1007/s00420-003-0470-5
10.1016/S0041-008X(03)00326-0
10.1016/S0892-0362(01)00170-2
10.1002/ps.2780270406
10.1074/jbc.M113.485227
10.1016/0041-008X(91)90270-O
10.1016/j.neuro.2008.09.011
10.1097/FPC.0b013e3280119d62
10.1016/j.neuro.2011.12.016
10.1186/1756-6606-4-26
10.1038/mp.2012.29
10.1007/BF01277656
10.1093/toxsci/kfp258
10.1073/pnas.79.14.4456
10.1016/j.envres.2008.03.002
10.1126/science.2953072
10.1016/j.ntt.2011.06.004
10.1289/ehp.0901275
10.1146/annurev.en.34.010189.000453
10.1038/379606a0
10.1016/S0300-483X(01)00569-8
10.1017/S0317167100041536
10.1016/j.ijheh.2011.12.003
10.1093/toxsci/kfm192
10.1007/BF01239644
10.1523/JNEUROSCI.18-06-01979.1998
10.1016/j.envres.2006.11.011
10.1002/aja.1002030302
10.1124/jpet.108.141713
10.1038/79951
10.1001/archneur.1978.00500310065014
10.1016/S0306-4522(98)00555-7
10.1016/j.ejphar.2006.06.042
ContentType Journal Article
Copyright The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2015
Copyright_xml – notice: The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
– notice: The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2015
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.1093/toxsci/kfv087
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1096-0929
EndPage 243
ExternalDocumentID 10_1093_toxsci_kfv087
25912032
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIEHS NIH HHS
  grantid: R01ES015991
– fundername: NIEHS NIH HHS
  grantid: R56ES018863
– fundername: NIEHS NIH HHS
  grantid: R21ES013828
– fundername: NIEHS NIH HHS
  grantid: P30ES005022
GroupedDBID ---
--K
-E4
.2P
.I3
.ZR
0R~
123
18M
1B1
1TH
1~5
29Q
2WC
4.4
48X
4G.
53G
5RE
5VS
5WA
5WD
7-5
70D
A8Z
AABZA
AACTN
AACZT
AAEDT
AAHBH
AAIMJ
AAJKP
AAJQQ
AALRI
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AAQXK
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWDT
AAXUO
ABEUO
ABIXL
ABJNI
ABKDP
ABMAC
ABMNT
ABNHQ
ABNKS
ABPTD
ABQLI
ABQTQ
ABWST
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACMRT
ACUFI
ACUTJ
ACUTO
ADBBV
ADEYI
ADEZT
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADMUD
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFGWE
AFIYH
AFOFC
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AHXPO
AIJHB
AJEEA
AKHUL
AKRWK
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ANFBD
APIBT
APWMN
AQDSO
ARIXL
ASPBG
ATGXG
ATTQO
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSWAC
BTRTY
BVRKM
CAG
CDBKE
CGR
COF
CS3
CUY
CVF
CZ4
DAKXR
DIK
DILTD
DM4
DU5
D~K
E3Z
EBD
EBS
ECM
EDH
EE~
EIF
EJD
ELUNK
EMOBN
ESTFP
F5P
F9B
FDB
FEDTE
FGOYB
FHSFR
FIRID
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HH5
HVGLF
HW0
HZ~
I-F
IHE
IOX
J21
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
LG5
M-Z
M49
N9A
NGC
NLBLG
NOMLY
NOYVH
NPM
NQ-
NTWIH
NU-
NVLIB
O-L
O0~
O9-
OAWHX
OBOKY
OCZFY
ODMLO
OHT
OJQWA
OJZSN
OK1
OPAEJ
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
Q1.
Q5Y
R2-
R44
RD5
RIG
RNI
ROL
ROX
RPZ
RUSNO
RW1
RXO
RZO
SSZ
SV3
TJX
TLC
TR2
UHS
W8F
WOQ
X7H
XPP
YAYTL
YCJ
YKOAZ
YXANX
ZGI
ZKX
ZMT
ZXP
~02
~91
AASNB
AAYXX
CITATION
KC5
5PM
ID FETCH-LOGICAL-c387t-14afee80a0a9dc36cf4e5468b13f42d2b0d2644b5eba6a2e66e828272de0f3473
ISSN 1096-6080
IngestDate Tue Sep 17 21:17:14 EDT 2024
Thu Sep 26 15:50:17 EDT 2024
Tue Oct 15 23:52:11 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords developmental exposure
locomotor activity
zebrafish
dopamine
pyrethroid
Language English
License The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c387t-14afee80a0a9dc36cf4e5468b13f42d2b0d2644b5eba6a2e66e828272de0f3473
OpenAccessLink https://academic.oup.com/toxsci/article-pdf/146/2/235/16688279/kfv087.pdf
PMID 25912032
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4517053
crossref_primary_10_1093_toxsci_kfv087
pubmed_primary_25912032
PublicationCentury 2000
PublicationDate 2015-08-01
PublicationDateYYYYMMDD 2015-08-01
PublicationDate_xml – month: 08
  year: 2015
  text: 2015-08-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Toxicological sciences
PublicationTitleAlternate Toxicol Sci
PublicationYear 2015
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References 14551781 - Int Arch Occup Environ Health. 2004 Jan;77(1):67-72
21663703 - Mol Brain. 2011;4:26
12003754 - Environ Health Perspect. 2002 May;110(5):507-14
16859670 - Eur J Pharmacol. 2006 Aug 21;544(1-3):58-68
23912772 - Psychopharmacology (Berl). 2014 Jan;231(1):109-22
8628395 - Nature. 1996 Feb 15;379(6566):606-12
22508465 - Mol Psychiatry. 2012 Sep;17(9):946-54
6956874 - Proc Natl Acad Sci U S A. 1982 Jul;79(14):4456-60
3404444 - J Pharmacol Exp Ther. 1988 Aug;246(2):514-21
21741476 - Neurotoxicol Teratol. 2011 Nov-Dec;33(6):668-73
11792535 - Neurotoxicol Teratol. 2001 Nov-Dec;23(6):665-73
25630971 - FASEB J. 2015 May;29(5):1960-72
1977890 - J Neurochem. 1990 Dec;55(6):2111-6
17140720 - Toxicology. 2007 Jan 18;229(3):194-205
8332631 - Pharmacol Biochem Behav. 1993 Jul;45(3):729-32
2006507 - Toxicol Appl Pharmacol. 1991 Mar 15;108(1):78-85
20129874 - Environ Health Perspect. 2010 Jun;118(6):742-8
11017081 - Nat Genet. 2000 Oct;26(2):216-20
15687048 - Environ Health Perspect. 2005 Feb;113(2):123-36
11829414 - Neurotoxicology. 2001 Dec;22(6):811-7
14575646 - Toxicol Appl Pharmacol. 2003 Nov 1;192(3):287-93
2872638 - Neurotoxicology. 1986 Spring;7(1):143-53
8589427 - Dev Dyn. 1995 Jul;203(3):253-310
22954718 - Behav Brain Res. 2013 Jan 1;236(1):139-47
19459224 - Neurotoxicology. 2009 Mar;30(2):274-80
22892382 - Environ Int. 2012 Nov 1;48:109-20
12428726 - Neurotoxicology. 2002 Oct;23(4-5):537-44
22245043 - Neurotoxicology. 2012 Aug;33(4):810-6
16736054 - J Expo Sci Environ Epidemiol. 2007 Jul;17(4):331-49
17728286 - Toxicol Sci. 2007 Nov;100(1):168-79
19306213 - J Occup Environ Hyg. 2009 Jun;6(6):341-52
17496723 - Pharmacogenet Genomics. 2007 Apr;17(4):237-53
2953072 - Science. 1987 May 8;236(4802):719-22
15567422 - Neuropharmacology. 2004 Dec;47(8):1117-34
566540 - Arch Neurol. 1978 Jul;35(7):463-9
1349263 - Can J Neurol Sci. 1992 Feb;19(1 Suppl):147-52
18952124 - Neurotoxicology. 2009 Jan;30(1):52-8
18436207 - Environ Res. 2008 Jul;107(3):343-50
1978240 - Mol Pharmacol. 1990 Oct;38(4):531-41
22218106 - Int J Hyg Environ Health. 2012 Sep;215(5):487-95
21555338 - Toxicol Sci. 2011 Aug;122(2):512-25
17258193 - Environ Res. 2007 Jun;104(2):266-74
2905952 - Comp Biochem Physiol C. 1988;91(2):371-5
9708845 - Behav Brain Res. 1998 Jul;94(1):127-52
8036717 - Trends Genet. 1994 May;10(5):152-9
16956637 - Toxicol Appl Pharmacol. 2006 Nov 15;217(1):25-34
10826982 - Curr Opin Genet Dev. 2000 Jun;10(3):252-6
2539040 - Annu Rev Entomol. 1989;34:77-96
9295170 - J Neural Transm (Vienna). 1997;104(4-5):341-62
1357592 - Neuroscience. 1992 Sep;50(1):137-47
1498477 - Bull Environ Contam Toxicol. 1992 Sep;49(3):402-9
12515682 - Environ Health Perspect. 2003 Jan;111(1):79-84
15949994 - Biol Psychiatry. 2005 Jun 1;57(11):1239-47
10366011 - Neuroscience. 1999;91(2):537-47
16673815 - Biomed Environ Sci. 2006 Feb;19(1):27-34
18698001 - J Pharmacol Exp Ther. 2008 Nov;327(2):554-60
9482784 - J Neurosci. 1998 Mar 15;18(6):1979-86
23754283 - J Biol Chem. 2013 Aug 2;288(31):22451-9
16005927 - Toxicol Appl Pharmacol. 2006 Mar 15;211(3):188-97
19861644 - Toxicol Sci. 2010 Jan;113(1):177-86
11812616 - Toxicology. 2002 Feb 1;171(1):3-59
2016080102451721000_146.2.235.39
2016080102451721000_146.2.235.38
2016080102451721000_146.2.235.37
2016080102451721000_146.2.235.36
2016080102451721000_146.2.235.35
2016080102451721000_146.2.235.33
2016080102451721000_146.2.235.32
2016080102451721000_146.2.235.30
Barton (2016080102451721000_146.2.235.4) 1990; 38
Fortin (2016080102451721000_146.2.235.19) 2008; 107
2016080102451721000_146.2.235.49
2016080102451721000_146.2.235.48
2016080102451721000_146.2.235.6
2016080102451721000_146.2.235.47
2016080102451721000_146.2.235.7
2016080102451721000_146.2.235.46
2016080102451721000_146.2.235.45
2016080102451721000_146.2.235.44
2016080102451721000_146.2.235.43
Hudson (2016080102451721000_146.2.235.31) 1986; 7
2016080102451721000_146.2.235.42
2016080102451721000_146.2.235.8
2016080102451721000_146.2.235.9
2016080102451721000_146.2.235.40
2016080102451721000_146.2.235.50
2016080102451721000_146.2.235.2
2016080102451721000_146.2.235.3
2016080102451721000_146.2.235.1
Berkowitz (2016080102451721000_146.2.235.5) 2003; 111
2016080102451721000_146.2.235.18
2016080102451721000_146.2.235.17
2016080102451721000_146.2.235.15
2016080102451721000_146.2.235.59
2016080102451721000_146.2.235.14
2016080102451721000_146.2.235.58
2016080102451721000_146.2.235.13
Liu (2016080102451721000_146.2.235.41) 2006; 19
2016080102451721000_146.2.235.57
2016080102451721000_146.2.235.12
2016080102451721000_146.2.235.11
2016080102451721000_146.2.235.55
2016080102451721000_146.2.235.10
2016080102451721000_146.2.235.54
2016080102451721000_146.2.235.52
2016080102451721000_146.2.235.51
2016080102451721000_146.2.235.61
2016080102451721000_146.2.235.60
Shafer (2016080102451721000_146.2.235.56) 2005; 113
Eells (2016080102451721000_146.2.235.16) 1988; 246
2016080102451721000_146.2.235.29
2016080102451721000_146.2.235.28
2016080102451721000_146.2.235.27
2016080102451721000_146.2.235.26
Robertson (2016080102451721000_146.2.235.53) 1992; 19
2016080102451721000_146.2.235.25
2016080102451721000_146.2.235.24
Jones (2016080102451721000_146.2.235.34) 1998; 18
2016080102451721000_146.2.235.23
2016080102451721000_146.2.235.22
2016080102451721000_146.2.235.21
2016080102451721000_146.2.235.65
2016080102451721000_146.2.235.20
2016080102451721000_146.2.235.64
2016080102451721000_146.2.235.63
2016080102451721000_146.2.235.62
References_xml – ident: 2016080102451721000_146.2.235.27
  doi: 10.1016/j.neuropharm.2004.07.034
– ident: 2016080102451721000_146.2.235.10
  doi: 10.1007/s00213-013-3212-8
– ident: 2016080102451721000_146.2.235.6
  doi: 10.1016/S0161-813X(02)00031-1
– ident: 2016080102451721000_146.2.235.52
  doi: 10.1096/fj.14-260901
– ident: 2016080102451721000_146.2.235.48
– ident: 2016080102451721000_146.2.235.47
  doi: 10.1016/j.tox.2006.10.015
– ident: 2016080102451721000_146.2.235.28
  doi: 10.1093/toxsci/kfr111
– ident: 2016080102451721000_146.2.235.35
  doi: 10.1016/S0161-813X(01)00063-8
– ident: 2016080102451721000_146.2.235.55
  doi: 10.1016/j.neuro.2008.12.015
– volume: 111
  start-page: 79
  year: 2003
  ident: 2016080102451721000_146.2.235.5
  article-title: Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort
  publication-title: Environ. Health Perspect.
  doi: 10.1289/ehp.5619
  contributor:
    fullname: Berkowitz
– volume: 246
  start-page: 514
  year: 1988
  ident: 2016080102451721000_146.2.235.16
  article-title: Pyrethroid insecticides evoke neurotransmitter release from rabbit striatal slices
  publication-title: J. Pharmacol. Exp. Ther.
  contributor:
    fullname: Eells
– ident: 2016080102451721000_146.2.235.65
  doi: 10.1289/ehp.02110507
– ident: 2016080102451721000_146.2.235.14
  doi: 10.1016/S0959-437X(00)00074-5
– ident: 2016080102451721000_146.2.235.58
  doi: 10.1016/j.bbr.2012.08.032
– ident: 2016080102451721000_146.2.235.62
  doi: 10.1016/S0166-4328(97)00175-7
– ident: 2016080102451721000_146.2.235.7
  doi: 10.1038/sj.jes.7500507
– ident: 2016080102451721000_146.2.235.37
  doi: 10.1006/pest.1999.2440
– ident: 2016080102451721000_146.2.235.1
  doi: 10.1016/j.envint.2012.07.007
– ident: 2016080102451721000_146.2.235.9
  doi: 10.1080/15459620902850907
– ident: 2016080102451721000_146.2.235.15
  doi: 10.1016/0168-9525(94)90091-4
– ident: 2016080102451721000_146.2.235.17
  doi: 10.1016/j.taap.2005.06.003
– ident: 2016080102451721000_146.2.235.30
  doi: 10.1016/0306-4522(92)90388-I
– ident: 2016080102451721000_146.2.235.2
  doi: 10.1111/j.1471-4159.1990.tb05803.x
– volume: 19
  start-page: 27
  year: 2006
  ident: 2016080102451721000_146.2.235.41
  article-title: Tyrosine hydroxylase as a target for deltamethrin in the nigrostriatal dopaminergic pathway
  publication-title: Biomed. Environ. Sci.
  contributor:
    fullname: Liu
– ident: 2016080102451721000_146.2.235.13
  doi: 10.1016/0305-0491(88)90156-3
– ident: 2016080102451721000_146.2.235.29
  doi: 10.1016/j.taap.2006.07.011
– ident: 2016080102451721000_146.2.235.43
  doi: 10.1016/0091-3057(93)90532-X
– volume: 113
  start-page: 123
  year: 2005
  ident: 2016080102451721000_146.2.235.56
  article-title: Developmental neurotoxicity of pyrethroid insecticides: Critical review and future research needs
  publication-title: Environ. Health Perspect.
  doi: 10.1289/ehp.7254
  contributor:
    fullname: Shafer
– ident: 2016080102451721000_146.2.235.54
  doi: 10.1016/j.biopsych.2005.02.002
– ident: 2016080102451721000_146.2.235.25
  doi: 10.1007/s00420-003-0470-5
– ident: 2016080102451721000_146.2.235.21
  doi: 10.1016/S0041-008X(03)00326-0
– ident: 2016080102451721000_146.2.235.39
  doi: 10.1016/S0892-0362(01)00170-2
– ident: 2016080102451721000_146.2.235.12
  doi: 10.1002/ps.2780270406
– ident: 2016080102451721000_146.2.235.50
  doi: 10.1074/jbc.M113.485227
– ident: 2016080102451721000_146.2.235.18
  doi: 10.1016/0041-008X(91)90270-O
– ident: 2016080102451721000_146.2.235.42
  doi: 10.1016/j.neuro.2008.09.011
– ident: 2016080102451721000_146.2.235.51
  doi: 10.1097/FPC.0b013e3280119d62
– ident: 2016080102451721000_146.2.235.20
  doi: 10.1016/j.neuro.2011.12.016
– ident: 2016080102451721000_146.2.235.24
  doi: 10.1186/1756-6606-4-26
– ident: 2016080102451721000_146.2.235.38
  doi: 10.1038/mp.2012.29
– volume: 38
  start-page: 531
  year: 1990
  ident: 2016080102451721000_146.2.235.4
  article-title: Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells
  publication-title: Mol. Pharmacol.
  contributor:
    fullname: Barton
– ident: 2016080102451721000_146.2.235.8
  doi: 10.1007/BF01277656
– ident: 2016080102451721000_146.2.235.11
  doi: 10.1093/toxsci/kfp258
– ident: 2016080102451721000_146.2.235.44
  doi: 10.1073/pnas.79.14.4456
– volume: 107
  start-page: 343
  year: 2008
  ident: 2016080102451721000_146.2.235.19
  article-title: Biological monitoring of exposure to pyrethrins and pyrethroids in a metropolitan population of the Province of Quebec, Canada
  publication-title: Environ. Res.
  doi: 10.1016/j.envres.2008.03.002
  contributor:
    fullname: Fortin
– ident: 2016080102451721000_146.2.235.64
  doi: 10.1126/science.2953072
– ident: 2016080102451721000_146.2.235.40
  doi: 10.1016/j.ntt.2011.06.004
– ident: 2016080102451721000_146.2.235.3
  doi: 10.1289/ehp.0901275
– ident: 2016080102451721000_146.2.235.60
  doi: 10.1146/annurev.en.34.010189.000453
– ident: 2016080102451721000_146.2.235.22
  doi: 10.1038/379606a0
– ident: 2016080102451721000_146.2.235.61
  doi: 10.1016/S0300-483X(01)00569-8
– volume: 19
  start-page: 147
  year: 1992
  ident: 2016080102451721000_146.2.235.53
  article-title: Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson’s disease: sites of action and implications for the pathogenesis of dyskinesias
  publication-title: Can. J. Neurol. Sci.(Le journal canadien des sciences neurologiques)
  doi: 10.1017/S0317167100041536
  contributor:
    fullname: Robertson
– ident: 2016080102451721000_146.2.235.23
– ident: 2016080102451721000_146.2.235.49
  doi: 10.1016/j.ijheh.2011.12.003
– ident: 2016080102451721000_146.2.235.26
  doi: 10.1093/toxsci/kfm192
– ident: 2016080102451721000_146.2.235.32
  doi: 10.1007/BF01239644
– volume: 18
  start-page: 1979
  year: 1998
  ident: 2016080102451721000_146.2.235.34
  article-title: Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.18-06-01979.1998
  contributor:
    fullname: Jones
– volume: 7
  start-page: 143
  year: 1986
  ident: 2016080102451721000_146.2.235.31
  article-title: Neurobehavioral effects of permethrin are associated with alterations in regional levels of biogenic amine metabolites and amino acid neurotransmitters
  publication-title: Neurotoxicology
  contributor:
    fullname: Hudson
– ident: 2016080102451721000_146.2.235.45
  doi: 10.1016/j.envres.2006.11.011
– ident: 2016080102451721000_146.2.235.36
  doi: 10.1002/aja.1002030302
– ident: 2016080102451721000_146.2.235.63
  doi: 10.1124/jpet.108.141713
– ident: 2016080102451721000_146.2.235.46
  doi: 10.1038/79951
– ident: 2016080102451721000_146.2.235.57
  doi: 10.1001/archneur.1978.00500310065014
– ident: 2016080102451721000_146.2.235.59
  doi: 10.1016/S0306-4522(98)00555-7
– ident: 2016080102451721000_146.2.235.33
  doi: 10.1016/j.ejphar.2006.06.042
SSID ssj0011609
Score 2.4290338
Snippet Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are...
SourceID pubmedcentral
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 235
SubjectTerms Alteration in Zebrafish Dopamine Function by Deltamethrin
Animals
Female
Gene Expression Regulation, Developmental - drug effects
In Vitro Techniques
Insecticides - toxicity
Methylphenidate - pharmacology
Nitriles - toxicity
Pregnancy
Prenatal Exposure Delayed Effects
Pyrethrins - toxicity
Receptors, Dopamine D1 - genetics
Receptors, Dopamine D2 - genetics
Swimming
Zebrafish - embryology
Title Developmental Deltamethrin Exposure Causes Persistent Changes in Dopaminergic Gene Expression, Neurochemistry, and Locomotor Activity in Zebrafish
URI https://www.ncbi.nlm.nih.gov/pubmed/25912032
https://pubmed.ncbi.nlm.nih.gov/PMC4517053
Volume 146
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiEkhKDAKDf5AfVlTec4zu2xKqBpFzSNTky8VIljaxGQTG2KNn4Gv4sfxXHsOAnsYfASRbmcqj1fj4_t73wHoTcJoVlMGHNkFDGHeUw6MCxIh4O3iRBBmNQCpscfgv0zdnDunw8GvzqspU2VTvmPG-tK_sercA38qqpk_8Gz1ihcgHPwLxzBw3C8lY87jB8VvcTXKlEdoVd5oSSMS7X4tztPNmuxrpnuyqNFZQoKah7sW5gyf6vL_3JeK1Cr9zQzVtdhKekO3vSEa5ieRyVXHL5SsetN8wmw9VltQct8fdHNdxflVc5tfDXDbWf_SEeaRS6l4h18nNr9n1452EGi-iSe2rvzsrw0ZBCh1pHbO7bf31G5yndn0-6ihutbSl0Th2Fm5QREN3maivYaic0CSRO8zQJm3plEm1CsZVDMqE61GNRfA4YW06rKK_gF4OSL_E5MAtCT5v5jyLRERr2F7y21gaV-_Q7aphD2IN5uzw5PPx3aXS03qClH9ssZzVcwsKcN7GkDvRzJJkZ90m4nC1o8RA_M9AXPNBYfoYEohujusSFoDNH4REuhX0_woq3sW0_wGJ-0IunXQ3RfrxdjXQb3GP3sYRl3sYwbLGONZdxiGRssY3iqi2WssIxbLE9wH8kTDDjGFse4wbGyY3H8BJ29f7eY7zumX4jDvSisHJclUoiIJCSJM-4FXDLhsyBKXU8ymtGUZCr9T32RJkFCRRCIiEY0pJkg0mOh9xRtFWUhniHM_NiDCMa5mzIWMTfOfBb7saQhSQlLxQiNGw8tL7UszPJGLIzQjnabfYz6sUuJR0co7DnUPqAE3_t3ivyiFn5nvhK_8p7f9sNfoHvtn-sl2qpWG_EKcugqfW2g-RsHrNTz
link.rule.ids 230,315,783,787,888,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Developmental+Deltamethrin+Exposure+Causes+Persistent+Changes+in+Dopaminergic+Gene+Expression%2C+Neurochemistry%2C+and+Locomotor+Activity+in+Zebrafish&rft.jtitle=Toxicological+sciences&rft.au=Kung%2C+Tiffany+S.&rft.au=Richardson%2C+Jason+R.&rft.au=Cooper%2C+Keith+R.&rft.au=White%2C+Lori+A.&rft.date=2015-08-01&rft.issn=1096-6080&rft.eissn=1096-0929&rft.volume=146&rft.issue=2&rft.spage=235&rft.epage=243&rft_id=info:doi/10.1093%2Ftoxsci%2Fkfv087&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_toxsci_kfv087
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1096-6080&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1096-6080&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1096-6080&client=summon